Extensive technical support, resources, and continuous monitoring are required to introduce new and underutilized vaccines. In this blog post, JSI’s Michel Othepa lays out process of new vaccine introduction.
HPV affects millions and millions of people. HPV is the most common sexually transmitted infection, and an estimated 20 million people have the active virus at any time, according to WHO. While in the U.S., the HPV vaccine was licensed for girls in 2006, and for boys in 2009, in many other countries, the vaccine is only just being rolled out now. JSI’s Allison Hackbarth and Vanessa Richart describes efforts being made internationally in and in the U.S. to expand access to HPV vaccine.